+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Latin America In Vitro Diagnostics Market Size, Share & Trends Report Analysis By Product (Instruments, Reagents), By Technology (Immunoassay), By Application (Infectious Diseases), By End-use, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 90 Pages
  • September 2023
  • Region: Latin America
  • Grand View Research
  • ID: 5893201
Description Jump to:
The Latin America in vitro diagnostics market size is expected to reach USD 5.2 billion by 2030, expanding at a CAGR of 1.6% from 2023 to 2030. The Latin America IVD market is expected to grow at a significant CAGR till 2024 owing to the rising prevalence of target disorders, aging population, and the presence of favorable government initiatives for early disease diagnosis. Other factors that are anticipated to boost the growth include the introduction of technologically advanced instruments and the increasing R&D initiatives for the development of disease-specific kits.

Regular testing for diabetes, cardiovascular, cancer, and sexually transmitted diseases are necessary for the timely treatments, further avoiding the risk of fatal health complications. The availability of tests for home and near patient testing is estimated to further enhance the usage rates of these devices. From November 2015, the Anvisa, which is a regulatory body for medical devices in Brazil, has started allowing the registration for HIV self-testing kits.

The increasing adoption point of care devices coupled with the increasing awareness among the healthcare professionals regarding the early diagnosis of various diseases has provided a boost to the Latin IVD market. The rising epidemic of communicable diseases in the southernpart of Latin America, the growing need for rapid and accurate diagnostics, and the changing healthcare infrastructure scenario are some of the key drivers of the Latin IVD market.

Latin America In Vitro Diagnostics Market Report Highlights

  • The instrument segment is one of the most important segments of in vitro diagnostics. The presence of highly automated analyzers and the availability of over the counter products are some of the factors responsible for its significant share.
  • The Molecular diagnostics segment is anticipated to be the fastest growing technology over the decade. Molecular diagnostics is a transformative area of diagnostics. The continuous innovation in technology helps the physicians for critical decision making
  • The home care segment is estimated to witness a significant growth over the forecast period. The high number of R&D initiatives undertaken by key competitors for the development of portable IVD devices with improved sensitivity and user-friendliness is a key factor attributing towards its growth.
  • In 2022, Brazil was the largest regional segment, owing to the established healthcare infrastructure, growing awareness for cancer screening, and the increasing demand for genetic testing.
  • Key players operating in the Latin America IVD market are Roche Diagnostics, Abbott Laboratories, Inc., Hologic (Gen-Probe), Becton Dickinson (BD) Company, Alere, Inc., Bio-Rad Laboratories, Qiagen N.V., Inc., bioMerieux, BioQuidel Corporation, and Siemens Healthcare.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Technology
1.1.3. Application
1.1.4. End use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Technology outlook
2.2.3. Application outlook
2.2.4. End use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Latin America In Vitro Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Latin America In Vitro Diagnostics Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Latin America In Vitro Diagnostics: Product Estimates & Trend Analysis
4.1. Latin America In Vitro Diagnostics Market: Key Takeaways
4.2. Latin America In Vitro Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Instruments
4.3.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Reagents
4.4.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Software
4.5.1. Software market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Latin America In Vitro Diagnostics: Technology Estimates & Trend Analysis
5.1. Latin America In Vitro Diagnostics Market: Key Takeaways
5.2. Latin America In Vitro Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Immunoassay
5.3.1. Immunoassay market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Hematology
5.4.1. Hematology market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Clinical Chemistry
5.5.1. Clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Molecular Diagnostics
5.6.1. Molecular diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Coagulation
5.7.1. Coagulation market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Microbiology
5.8.1. Microbiology market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Latin America In Vitro Diagnostics: Application Estimates & Trend Analysis
6.1. Latin America In Vitro Diagnostics Market: Key Takeaways
6.2. Latin America In Vitro Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Infectious Disease
6.3.1. Infectious disease market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Diabetes
6.4.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Oncology/Cancer
6.5.1. Oncology/cancer market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Cardiology
6.6.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Nephrology
6.7.1. Nephrology market estimates and forecasts, 2018 to 2030 (USD Million)
6.8. Autoimmune Diseases
6.8.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
6.9. Drug Testing
6.9.1. Drug testing market estimates and forecasts, 2018 to 2030 (USD Million)
6.10. Others
6.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Latin America In Vitro Diagnostics: End Use Estimates & Trend Analysis
7.1. Latin America In Vitro Diagnostics Market: Key Takeaways
7.2. Latin America In Vitro Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Hospitals
7.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Laboratory
7.4.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Home Care
7.5.1. Home care market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Others
7.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Latin America In Vitro Diagnostics Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Latin America In Vitro Diagnostics Market by Region: Key Takeaways
8.3. Latin America
8.3.1. Brazil
8.3.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.3.2. Mexico
8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.3.3. Argentina
8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Market Participant Categorization
9.2.1. BD
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. BIOMÉRIEUX
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Abbott.
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Quidel Corporation.
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. OraSure Technologies
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Hologic, Inc.
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Cepheid.
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. QIAGEN
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. F. Hoffmann-La Roche Ltd.
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Siemens Healthcare GmbH
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives
9.2.11. Bio-Rad Laboratories, Inc.
9.2.11.1. Company overview
9.2.11.2. Financial performance
9.2.11.3. Product benchmarking
9.2.11.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 Latin America in vitro diagnostics market, by product, 2018 - 2030 (USD Million)
Table 3 Latin America in vitro diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 4 Latin America in vitro diagnostics market, by application, 2018 - 2030 (USD Million)
Table 5 Latin America in vitro diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 6 Latin America in vitro diagnostics market, by region, 2018 - 2030 (USD Million)
Table 7 Brazil in vitro diagnostics market, by product, 2018 - 2030 (USD Million)
Table 8 Brazil in vitro diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 9 Brazil in vitro diagnostics market, by application, 2018 - 2030 (USD Million)
Table 10 Brazil in vitro diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 11 Mexico in vitro diagnostics market, by product, 2018 - 2030 (USD Million)
Table 12 Mexico in vitro diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 13 Mexico in vitro diagnostics market, by application, 2018 - 2030 (USD Million)
Table 14 Mexico in vitro diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 15 Argentina in vitro diagnostics market, by product, 2018 - 2030 (USD Million)
Table 16 Argentina in vitro diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 17 Argentina in vitro diagnostics market, by application, 2018 - 2030 (USD Million)
Table 18 Argentina in vitro diagnostics market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Latin America in vitro diagnostics: Market outlook
Fig. 9 Latin America in vitro diagnostics: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Latin America in vitro diagnostics market driver impact
Fig. 15 Latin America in vitro diagnostics market restraint impact
Fig. 16 Latin America in vitro diagnostics market strategic initiatives analysis
Fig. 17 Latin America in vitro diagnostics market: Product movement analysis
Fig. 18 Latin America in vitro diagnostics market: Product outlook and key takeaways
Fig. 19 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Software market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Latin America in vitro diagnostics market: Technology movement analysis
Fig. 23 Latin America in vitro diagnostics market: Technology outlook and key takeaways
Fig. 24 Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Hematology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Clinical chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Coagulation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Microbiology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Latin America in vitro diagnostics market: Application movement analysis
Fig. 32 Latin America in vitro diagnostics market: Application outlook and key takeaways
Fig. 33 Infectious disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Oncology/cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Nephrology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Autoimmune diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Drug testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Latin America in vitro diagnostics market: End use movement analysis
Fig. 42 Latin America in vitro diagnostics market: End use outlook and key takeaways
Fig. 43 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Laboratory market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Home care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Global Latin America in vitro diagnostics market: Regional movement analysis
Fig. 48 Global Latin America in vitro diagnostics market: Regional outlook and key takeaways
Fig. 49 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • BD
  • BIOMÉRIEUX
  • Abbott.
  • Quidel Corporation.
  • OraSure Technologies
  • Hologic, Inc.
  • Cepheid.
  • QIAGEN
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare GmbH
  • Bio-Rad Laboratories, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Global In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Forecast to 2029 - Product Image

Global In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Forecast to 2029

  • Report
  • 677 Pages
  • Global
From
United States In-Vitro Diagnostics Market, Size, Forecast 2024-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis - Product Image

United States In-Vitro Diagnostics Market, Size, Forecast 2024-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis

  • Report
  • 135 Pages
  • United States
From
North America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User - Product Image

North America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User

  • Report
  • 112 Pages
  • North America
From
In Vitro Diagnostics Business Outlook - Product Image

In Vitro Diagnostics Business Outlook

  • Newsletter
  • Global
From
Global Endocrine Testing Market Size, Share & Trends Analysis Report by Test Type (TSH, hCG Hormone), End-use (Hospitals, Commercial Laboratories), Technology (Immunoassay, Clinical Chemistry), and Segment Forecasts, 2024-2030 - Product Image

Global Endocrine Testing Market Size, Share & Trends Analysis Report by Test Type (TSH, hCG Hormone), End-use (Hospitals, Commercial Laboratories), Technology (Immunoassay, Clinical Chemistry), and Segment Forecasts, 2024-2030

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.